Search research articles
Contact Us
Filters
Showing results (1-10 of 43) with videos related to
Page
of 5
Sort By:
Current Opinion in Neurology
|
November 3, 2016
Recent advances in cerebrospinal fluid biomarkers for the detection of preclinical Alzheimer's disease
Luka Kulic, Paul G Unschuld
Plos One
|
September 23, 2020
Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system
Christian Tackenberg, Luka Kulic, Roger M Nitsch
Plos One
|
April 13, 2011
Chronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's disease
Susann Cattepoel, Michael Hanenberg, Luka Kulic, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Catherine J Mummery, Roberto Villaseñor, Jens Niewoehner, et al.
Neuro-Degenerative Diseases
|
February 7, 2018
Extravascular CD3+ T Cells in Brains of Alzheimer Disease Patients Correlate with Tau but Not with Amyloid Pathology: An Immunohistochemical Study
Mario Merlini, Tunahan Kirabali, Luka Kulic, et al.
Brain Pathology (Zurich, Switzerland)
|
September 1, 2020
Distinct changes in all major components of the neurovascular unit across different neuropathological stages of Alzheimer's disease
Tunahan Kirabali, Ruslan Rust, Serena Rigotti, et al.
Neuroimage
|
April 2, 2016
Complex interplay between brain function and structure during cerebral amyloidosis in APP transgenic mouse strains revealed by multi-parametric MRI comparison
Joanes Grandjean, Rebecca Derungs, Luka Kulic, et al.
Neurobiology of Disease
|
November 18, 2005
Active immunization trial in Abeta42-injected P301L tau transgenic mice
Luka Kulic, Pascal Kurosinski, Feng Chen, et al.
Acta Neuropathologica Communications
|
December 5, 2019
The amyloid-β degradation intermediate Aβ34 is pericyte-associated and reduced in brain capillaries of patients with Alzheimer's disease
Tunahan Kirabali, Serena Rigotti, Alessandro Siccoli, et al.
Frontiers in Aging Neuroscience
|
September 25, 2014
Reciprocal modulation of Aβ42 aggregation by copper and homocysteine
Salla Keskitalo, Melinda Farkas, Michael Hanenberg, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 43) with videos related to
Sort By:
Page
of 5
Current Opinion in Neurology
|
November 3, 2016
Recent advances in cerebrospinal fluid biomarkers for the detection of preclinical Alzheimer's disease
Luka Kulic, Paul G Unschuld
Plos One
|
September 23, 2020
Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system
Christian Tackenberg, Luka Kulic, Roger M Nitsch
Plos One
|
April 13, 2011
Chronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's disease
Susann Cattepoel, Michael Hanenberg, Luka Kulic, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Catherine J Mummery, Roberto Villaseñor, Jens Niewoehner, et al.
Neuro-Degenerative Diseases
|
February 7, 2018
Extravascular CD3+ T Cells in Brains of Alzheimer Disease Patients Correlate with Tau but Not with Amyloid Pathology: An Immunohistochemical Study
Mario Merlini, Tunahan Kirabali, Luka Kulic, et al.
Brain Pathology (Zurich, Switzerland)
|
September 1, 2020
Distinct changes in all major components of the neurovascular unit across different neuropathological stages of Alzheimer's disease
Tunahan Kirabali, Ruslan Rust, Serena Rigotti, et al.
Neuroimage
|
April 2, 2016
Complex interplay between brain function and structure during cerebral amyloidosis in APP transgenic mouse strains revealed by multi-parametric MRI comparison
Joanes Grandjean, Rebecca Derungs, Luka Kulic, et al.
Neurobiology of Disease
|
November 18, 2005
Active immunization trial in Abeta42-injected P301L tau transgenic mice
Luka Kulic, Pascal Kurosinski, Feng Chen, et al.
Acta Neuropathologica Communications
|
December 5, 2019
The amyloid-β degradation intermediate Aβ34 is pericyte-associated and reduced in brain capillaries of patients with Alzheimer's disease
Tunahan Kirabali, Serena Rigotti, Alessandro Siccoli, et al.
Frontiers in Aging Neuroscience
|
September 25, 2014
Reciprocal modulation of Aβ42 aggregation by copper and homocysteine
Salla Keskitalo, Melinda Farkas, Michael Hanenberg, et al.
Page
of 5